<DOC>
	<DOCNO>NCT01895426</DOCNO>
	<brief_summary>The purpose study collect clinical radiological mid-term ( 2 year ) data ArcadiusXP L® lumbar stand-alone cage post-market clinical follow-up study ( PMCF ) limit 32 patient .</brief_summary>
	<brief_title>ArcadiusXP L Post Market Clinical Follow-Up</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>indication give instruction use Patients persist lumbosacral pseudoradicular pain schedule monosegmental lumbar interbody fusion L4 S1 Age 18 60 least 6 month unsuccessful treatment include conservative measure Nonsequestrated subligamentous prolapse contraindication , list instruction use . exist pregnancy , plan occur study period patient higher degree segmental degeneration segment operate body massindex ( BMI ) &gt; 30 Systemic local infection Increased risk osteoporosis accord assessment SCORE evaluation Bone metabolism disorder Chemotherapy radiotherapy ( ongoing plan ) Participation another clinical trial Scheduled spinal litigation Other serious condition hinder participation study Nanogel® filling cage , prior implantation do</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>